Literature DB >> 15962372

Effects of adrenomedullin gene overexpression on biological behavior of hepatic stellate cells.

Yi Wang1, Jin-Sheng Zhang, Guang-Cun Huang, Qi Cheng, Zhong-Hua Zhao.   

Abstract

AIM: To investigate the effects of adrenomedullin (AM) gene overexpression on the biological characteristics of human hepatic stellate cells (hHSCs) by stable transfection.
METHODS: hHSCs which express low basal levels of AM were stably transfected with an expression construct containing rat AM gene or with an empty expression vector. Expression of AM in hHSCs was determined by reverse transcription (RT)-polymerase chain reaction (PCR) and radioimmunoassay (RIA). Cell proliferation was evaluated by 5-bromo-2'-deoxyuridine (BrdU) incorporation and immunocytochemistry. RT-PCR and Western blot were used to test the expression of procollagen types I and III. Protein expressions of interstitial collagenase (MMP-1), gelatinase (MMP-2) and tissue inhibitors of matrix metalloproteinases-2 (TIMP-2) were assessed by Western blot.
RESULTS: Two cell clones (A-2, A-8) transfected with the AM gene expressed higher levels of AM mRNA (non-transfected group: 0.86+/-0.11, empty vector group: 1.01+/-0.11, A-2 clone group: 1.44+/-0.08 and A-8 clone group: 1.36+/-0.05) and protein (12.31+/-0.17, 12.35+/-0.12, 12.56+/-0.06 and 12.62+/-0.07) (P<0.05). AM gene overexpression had inhibitory effects on cell proliferation of hHSCs (29.6%, 30.9%, 18.9% and 21.8%, respectively. P<0.05) and expression of procollagen type I (0.58+/-0.1, 0.48+/-0.11, 0.3+/-0.06 and 0.31+/-0.07 at mRNA level) (0.27+/-0.07, 0.3+/-0.06, 0.14+/-0.05 and 0.13+/-0.05 at protein level) (P<0.05) and procollagen type III (0.17+/-0.04, 0.15+/-0.03, 0.1+/-0.02 and 0.09+/-0.02 at mRNA level) (0.22+/-0.04, 0.2+/-0.03, 0.11+/-0.04 and 0.13+/-0.03 at protein level) (P<0.05). Compared with cells non-transfected (TIMP2: 2.77+/-0.03, MMP-2: 0.5+/-0.04, MMP-1: 0.49+/-0.07) and transfected with empty vector (TIMP2: 2.79+/-0.04, MMP-2: 0.48+/-0.03, MMP-1: 0.45+/-0.09), these two clones had lower expression levels of TIMP2(A-2 clone group: 2.7+/-0.02 and A-8 clone group: 2.71+/-0.02) (P<0.05) and MMP-2(A-2 clone group: 0.15+/-0.05 and A-8 clone group: 0.13+/-0.04) (P<0.05) but displayed a higher expression level of MMP-1(A-2 clone group: 0.68+/-0.06 and A-8 clone group: 0.81+/-0.09) (P<0.05).
CONCLUSION: AM gene exerts negative influence to some extent on hHSCs by inhibiting proliferation and production of extracellular matrix (ECM) in addition to inducing MMP-1 expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962372      PMCID: PMC4315958          DOI: 10.3748/wjg.v11.i23.3549

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

Review 1.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

Review 2.  The AP-1 site and MMP gene regulation: what is all the fuss about?

Authors:  U Benbow; C E Brinckerhoff
Journal:  Matrix Biol       Date:  1997-03       Impact factor: 11.583

3.  Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas.

Authors:  N Théret; O Musso; B Turlin; D Lotrian; P Bioulac-Sage; J P Campion; K Boudjéma; B Clément
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

Review 4.  Signal transduction in hepatic stellate cells.

Authors:  M Pinzani; F Marra; V Carloni
Journal:  Liver       Date:  1998-02

5.  Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice.

Authors:  K Kovalovich; R A DeAngelis; W Li; E E Furth; G Ciliberto; R Taub
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

Review 6.  Pathogenesis of liver fibrosis.

Authors:  R Alcolado; M J Arthur; J P Iredale
Journal:  Clin Sci (Lond)       Date:  1997-02       Impact factor: 6.124

7.  Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts.

Authors:  T Horio; T Nishikimi; F Yoshihara; H Matsuo; S Takishita; K Kangawa
Journal:  Eur J Pharmacol       Date:  1999-10-01       Impact factor: 4.432

8.  Regulation of glomerular mesangial cell proliferation in culture by adrenomedullin.

Authors:  N Parameswaran; P Nambi; D P Brooks; W S Spielman
Journal:  Eur J Pharmacol       Date:  1999-05-07       Impact factor: 4.432

9.  Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells.

Authors:  S Sugo; N Minamino; H Shoji; K Kangawa; K Kitamura; T Eto; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1995-02-06       Impact factor: 3.575

10.  Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.

Authors:  Pei Niu; Takayuki Shindo; Hiroshi Iwata; Satoshi Iimuro; Norifumi Takeda; Yuelan Zhang; Aya Ebihara; Yoshihiro Suematsu; Kenji Kangawa; Yasunobu Hirata; Ryozo Nagai
Journal:  Circulation       Date:  2004-02-16       Impact factor: 29.690

View more
  5 in total

1.  Adrenomedullin regulates expressions of transforming growth factor-beta1 and beta1-induced matrix metalloproteinase-2 in hepatic stellate cells.

Authors:  Yi Wang; Jin-Sheng Zhang; Jin Qian; Guang-Cun Huang; Qi Chen
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

2.  Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models.

Authors:  Qing-He Nie; Ya-Fei Zhang; Yu-Mei Xie; Xin-Dong Luo; Bin Shao; Jun Li; Yong-Xing Zhou
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

3.  Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease.

Authors:  Ancha Baranova; Karen Schlauch; Hazem Elariny; Mohammed Jarrar; Chase Bennett; Clare Nugent; Shobha J Gowder; Zahra Younoszai; Rochelle Collantes; Vikas Chandhoke; Zobair M Younossi
Journal:  Obes Surg       Date:  2007-08       Impact factor: 4.129

4.  Mechanism of Hepatoprotective Effect of Boesenbergia rotunda in Thioacetamide-Induced Liver Damage in Rats.

Authors:  Suzy M Salama; Mahmood A Abdulla; Ahmed S Alrashdi; A Hamid A Hadi
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-07       Impact factor: 2.629

5.  PASS-predicted hepatoprotective activity of Caesalpinia sappan in thioacetamide-induced liver fibrosis in rats.

Authors:  Farkaad A Kadir; Normadiah M Kassim; Mahmood Ameen Abdulla; Behnam Kamalidehghan; Fatemeh Ahmadipour; Wageeh A Yehye
Journal:  ScientificWorldJournal       Date:  2014-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.